|
| |
| | | | 1 | | | DO1.PCCNTR.1388084 ContractData Container |
| | | 1.1 | | | | | | | | | | 296,929,680.00 | 0.00 | 0.00 | 0.00 | 279,670,248.40 | 296,929,680.00 |
|
| | | | | | | 5 | | 51111805 - Acetato de gos(...)51111805 - Acetato de goserelina |
| 2.3.4.1.01 | ATEZOLIZUMAB 1200 mg / 20 ml | 90 | UD | 384,000 | 384,000 | 34,560,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 34,560,000.00 | 34,560,000.00 | |
|
| | | | | | | 6 | | 51131501 - Fumarato ferro(...)51131501 - Fumarato ferroso |
| 2.3.4.1.01 | AZACITIDINA 100 mg / vial | 1,230 | UD | 5,000 | 14,590 | 17,945,700.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 6,150,000.00 | 17,945,700.00 | |
|
| | | | | | | 8 | | 2.3.4.1.01 | BEVACIZUMAB 100 mg / 4 ml | 119 | UD | 23,300 | 24,000 | 2,856,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 2,772,700.00 | 2,856,000.00 | |
|
| | | | | | | 9 | | 2.3.4.1.01 | BEVACIZUMAB 400 mg / 16 ml | 237 | UD | 91,130 | 96,000 | 22,752,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 21,597,810.00 | 22,752,000.00 | |
|
| | | | | | | 15 | | 2.3.4.1.01 | DORNASA ALFA 2.5 mg / 2.5 ml | 4,050 | UD | 2,350 | 2,350 | 9,517,500.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 9,517,500.00 | 9,517,500.00 | |
|
| | | | | | | 16 | | 2.3.4.1.01 | EMICIZUMAB 105 mg/ 0.7 ml | 123 | UD | 382,000 | 382,000 | 46,986,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 46,986,000.00 | 46,986,000.00 | |
|
| | | | | | | 17 | | 2.3.4.1.01 | EMICIZUMAB 30 mg/ 1 ml | 186 | UD | 110,000 | 110,000 | 20,460,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 20,460,000.00 | 20,460,000.00 | |
|
| | | | | | | 27 | | 2.3.4.1.01 | OBINUTUZUMAB 1000 mg / 40 ml | 62 | UD | 99,800 | 99,800 | 6,187,600.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 6,187,600.00 | 6,187,600.00 | |
|
| | | | | | | 34 | | 2.3.4.1.01 | PERTUZUMAB 420 mg / 14 ml | 292 | UD | 197,000 | 197,000 | 57,524,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 57,524,000.00 | 57,524,000.00 | |
|
| | | | | | | 36 | | 2.3.4.1.01 | RITUXIMAB 1400 mg / 11.7 ml | 13 | UD | 86,500 | 86,500 | 1,124,500.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 1,124,500.00 | 1,124,500.00 | |
|
| | | | | | | 40 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | TERIPARATIDA 250 mcg / 2.4 ml | 1,800 | UD | 28,620 | 30,350 | 54,630,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 51,516,000.00 | 54,630,000.00 | |
|
| | | | | | | 41 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | TOCILIZUMAB 162mg / 0.9ml | 620 | UD | 11,500 | 11,500 | 7,130,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 7,130,000.00 | 7,130,000.00 | |
|
| | | | | | | 42 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | TOCILIZUMAB 80 mg / 4 ml | 833 | UD | 6,900 | 6,900 | 5,747,700.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 5,747,700.00 | 5,747,700.00 | |
|
| | | | | | | 61 | | 2.3.4.1.01 | PIRFENIDONA 267 mg | 17,820 | UD | 340 | 334 | 5,951,880.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 6,058,800.00 | 5,951,880.00 | |
|
| | | | | | | 71 | | 51102333 - Hidrocloruro d(...)51102333 - Hidrocloruro de valganciclovir |
| 2.3.4.1.01 | VALGANCICLOVIR CLORHIDRATO 450 MG | 4,560 | UD | 512.64 | 780 | 3,556,800.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 2,337,638.40 | 3,556,800.00 | |
|
|
| | | |
| | | |
|